交易中 06-24 11:40:24 美东时间
+0.635
+0.16%
Keybanc analyst Samuel Kemp maintains Reliance (NYSE:RS) with a Overweight and raises the price target from $378 to $418.
今天 20:54
今日重点评级关注:Ascendiant Capital:维持NextTrip"买入"评级,目标价从7美元升至7.5美元;Maxim Group:维持Zevra Therapeutics"买入"评级,目标价从25美元升至35美元
06-11 09:55
今日重点评级关注:Ascendiant Capital:维持Vivos Therapeutics"买入"评级,目标价从3美元升至3.1美元;富国银行:维持Veeva Systems"超配"评级,目标价从317美元升至320美元
06-05 11:33
Wells Fargo analyst Timna Tanners maintains Reliance (NYSE:RS) with a Equal-Weight and raises the price target from $343 to $376.
06-04 21:13
Hewlett Packard stock surges 7% ahead of Q2 earnings. Analysts expect 54c EPS (up 42% YoY) as shares hit new 52-week highs.
06-01 18:04
International Flavors & Fragrances shares are down slightly after agreeing to sell its Food Ingredients unit to CVC for $4.3 billion.
05-30 01:50
Wise Group Plc. Ordinary Shares - Class A涨6.75%;恩智浦涨2.50%;IREN Limited涨2.48%
05-12 06:10
If your entire U.S. equity exposure sits in a standard cap-weighted S&P 500 fund, you are significantly overweight a cluster of AI and cloud megacap stocks, whether or not you chose them deliberately.
05-08 23:39
今日重点评级关注:Canaccord Genuity:维持Intellia Therapeutics"买入"评级,目标价从48美元升至58美元;富国银行:维持曼恩凯德生物医疗"超配"评级,目标价从7美元升至8美元
04-29 10:28
今日重点评级关注:Ascendiant Capital:维持NRX Pharmaceuticals"买入"评级,目标价从48美元升至49美元;Chardan Capital:维持Intellia Therapeutics"买入"评级,目标价从27美元升至30美元
04-28 10:07